The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Carbamazepine Essential Pharma 250 mg Suppositories



Essential Pharma (M) LimitedPA22644/003/002

Main Information

Trade NameCarbamazepine Essential Pharma 250 mg Suppositories
Active SubstancesCarbamazepine
Dosage FormSuppository
Licence HolderEssential Pharma (M) Limited
Licence NumberPA22644/003/002

Group Information

ATC CodeN03AF Carboxamide derivatives
N03AF01 carbamazepine

Status

License statusAuthorised
Licence Issued13/05/2016
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back